The Desmoid Tumor Research Foundation

January 2018

Pazopanib therapy for desmoid tumors in adolescent and young adult patients

Author Information

Agresta L(1), Kim H(2), Turpin BK(1), Nagarajan R(1), Plemmons A(2), Szabo S(3), Dasgupta R(4), Sorger JI(5), Pressey JG(1)

(1)Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.(2)Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.(3)Division of Pathology and Laboratory Medicine, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.(4)Department of Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.(5)Department of Orthopedic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Publication

Pediatr Blood Cancer

Summary

At our institution, we recently observed promising results with pazopanib therapy for DT/AF in adolescent and young adult (AYA) patients. Pazopanib provides a promising, well-tolerated therapy for DT/AF in the AYA population and warrants further study.

View Abstract